EMD-55201

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameEMD-55201
Drug Alias NameEMD-55201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone synthesis stimulants
TargetsUpdating
Therapy Area/IndicationsOsteoporosisBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck KGaA, Darmstadt, Germany
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsOsteoporosisBone Diseases

Other Information

ATC CodeN/A
Related LinksN/A